respiratori
infect
frequent
reason
primari
health
care
consult
main
caus
respiratori
tract
infect
children
virus
common
type
upper
respiratori
tract
infect
common
cold
pharyng
otiti
media
sinus
pneumonia
much
seriou
well
virus
bacteria
often
involv
respiratori
tract
infect
three
bacteri
speci
commonli
isol
streptococcu
pneumonia
nonencapsul
haemophilu
influenza
moraxella
branhamella
catarrhali
common
bacteri
caus
pharyng
streptococcu
pyogen
bacteria
isol
communityacquir
infect
usual
sensit
major
suitabl
drug
past
two
decad
signific
antibiot
resist
emerg
resist
penicillin
spread
among
h
influenza
pneumonia
mechan
penicillin
resist
h
influenza
mainli
product
blactamas
wherea
pneumonia
resist
effect
chang
penicillin
bind
protein
among
respiratori
pathogen
resist
tetracyclin
macrolid
trimethoprimsulphamethoxazol
fluoroquinolon
also
appear
sever
mechan
depend
chang
target
activ
efflux
modifi
enzym
involv
respiratori
infect
frequent
reason
primari
health
care
consult
one
fourth
one
third
patient
visit
gener
practition
suffer
acut
respiratori
tract
infect
arti
frequent
recognis
pharyng
common
cold
influenza
tonsil
nasopharyng
sinus
bronchiti
paediatr
respiratori
tract
infect
especi
associ
signific
morbid
mortal
arti
children
year
age
frequent
caus
death
lung
diseas
global
caus
million
death
annual
bacteri
viral
infect
carrier
state
upper
respiratori
tract
frequent
establish
level
immun
function
critic
mani
infect
potenti
pathogen
bacteria
often
present
nasopharyng
sampl
taken
healthi
children
preval
decreas
age
debat
whether
use
nasopharyng
sampl
discrimin
bacteri
viral
respiratori
tract
infect
need
evalu
patient
year
main
caus
respiratori
tract
infect
virus
sever
virus
associ
common
cold
syndrom
rhinovirus
adenovirus
influenza
parainfluenza
virus
coronavirus
respiratori
syncyti
virus
enterovirus
herpesvirus
less
frequent
recognis
upper
lower
respiratori
tract
infect
frequenc
particular
viru
differ
differ
infect
among
upper
respiratori
infect
common
cold
pharyng
otiti
media
frequent
encount
children
virus
bacteria
caus
acut
pharyng
group
bhaemolyt
streptococcu
caus
pharyng
import
pathogen
often
caus
suppur
nonsuppur
sequela
suppur
sequela
peritonsillar
abscess
otiti
media
acut
sinus
probabl
rare
today
mani
countri
antibiot
usual
use
earli
stage
diseas
nonsuppur
sequela
rheumat
fever
autoimmunolog
reaction
glomerulonephr
immunolog
complex
diseas
produc
specif
type
protein
streptococcu
pyogen
otiti
media
next
common
cold
commonli
diagnos
probabl
preval
ill
first
year
life
although
mainli
bacteri
aetiolog
author
question
necess
antimicrobi
therapi
evid
respiratori
virus
crucial
role
aetiolog
pathogenesi
infect
among
bacteri
speci
commonli
isol
streptococcu
pneumonia
nonencapsul
haemophilu
influenza
moraxella
branhamella
catarrhali
mix
infect
infrequ
common
disord
children
adult
sinus
agent
sinus
vari
accord
chronic
infect
age
underli
condit
patient
common
caus
sinus
children
pneumonia
h
influenza
unencapsul
catarrhali
chronic
sinus
anaerob
often
involv
infect
often
mix
infect
lower
respiratori
tract
bronchiti
pneumonia
often
seriou
infect
upper
respiratori
tract
pneumonia
common
children
adult
spectrum
organ
caus
pneumonia
also
differ
children
specif
agent
caus
pneumonia
newborn
young
children
chlamydia
trachomati
group
b
haemolyt
streptococci
older
children
aetiolog
agent
adult
viral
pneumonia
much
frequent
children
younger
year
age
h
influenza
type
b
much
common
caus
pneumonia
mening
frequent
viral
aetiolog
agent
commun
acquir
pneumonia
children
rsv
parainfluenza
adenoviru
common
bacteria
pneumonia
h
influenza
bacteria
aureu
pyogen
gramneg
bacteria
pneumonia
c
pneumonia
less
frequent
differ
pathogen
associ
hospit
acquir
pneumonia
children
cystic
fibrosi
one
common
locat
hospit
develop
nosocomi
infect
intens
care
unit
respiratori
tract
infect
common
infect
associ
ventil
therapi
rather
underli
medic
condit
common
isol
enterobacteriacea
aureu
predomin
organ
cystic
fibrosi
pseudomona
spp
aureu
previous
mention
predomin
agent
commun
acquir
lower
respiratori
tract
infect
pneumonia
h
influenza
catarrhali
pyogen
role
lower
respiratori
tract
infect
declin
last
year
past
two
decad
signific
antibiot
resist
emerg
among
bacteria
signific
chang
observ
among
strain
pneumonia
pneumonia
exquisit
suscept
penicillin
concentr
penicillin
less
mgl
bactericid
report
strain
pneumococci
intermedi
level
penicillin
resist
mic
mgl
began
appear
strain
possess
penicillin
mic
valu
greater
mgl
occur
unfortun
pneumococc
strain
resist
penicillin
usual
also
resist
mani
antibiot
like
macrolid
tetracyclin
cotrimoxazol
even
chloramphenicol
high
suscept
pneumonia
quinolon
still
seen
increas
prescript
antibiot
increas
resist
strain
area
mechan
pneumococc
resist
penicillin
g
blactam
antibiot
involv
alter
one
penicillin
bind
protein
pbp
caus
lower
affin
blactam
antibiot
pneumonia
five
high
molecular
weight
pbp
recognis
presum
alter
could
lead
increas
resist
blactam
moreov
shown
chang
low
molecular
weight
also
associ
resist
blactam
level
resist
determin
mani
extent
target
modifi
usual
alter
associ
mic
mgl
mani
paper
gene
nomin
respons
penicillin
nonsuscept
howev
sever
report
suggest
chang
highmolecular
weight
pbp
could
also
increas
penicillin
mic
valu
pneumonia
gene
determin
synthesi
alter
pbp
pneumococci
appear
mutat
also
acquir
differ
speci
streptococci
especi
oral
origen
gene
resist
pbp
pneumococci
show
specif
mosaic
structur
consist
segment
nativ
pneumococc
dna
mix
segment
foreign
dna
case
extend
spectrum
cephalosporin
carbapenem
possess
greater
activ
penicillin
strain
low
level
resist
although
pneumococci
resist
extend
spectrum
cephalosporin
penicillin
g
resist
penicillin
g
primarili
determin
chang
wherea
elev
resist
cephalosporin
determin
rather
chang
acquisit
penicillin
resist
pneumococci
accompani
reduct
pathogen
target
quinolon
bacteri
topoisomeras
enzym
essenti
cell
regul
dna
supercoil
level
caten
decaten
bacteri
chromosom
main
target
gyras
topoisomeras
iv
pneumococci
major
fluoroquinolon
act
preferenti
subunit
topoisomeras
iv
resist
pneumonia
fluoroquinolon
appear
mutat
gene
determin
topoisomeras
iv
parc
pare
gene
determin
gyras
gyra
gyrb
resist
fluoroquinolon
result
singl
mutat
one
gene
encod
enzym
second
mechan
resist
fluoroquinolon
depend
multidrug
efflux
describ
pneumococci
although
macrolid
lincosamid
antibiot
still
exhibit
high
activ
pneumonia
mani
countri
preval
resist
isol
rapidli
increas
eg
spain
itali
belgium
respect
least
five
phenotyp
resist
macrolid
describ
pneumonia
particular
mechan
depend
target
modif
efflux
first
common
mechan
determin
high
level
resist
crossresist
macrolid
lincosamid
streptogramin
b
ml
b
phenotyp
phenotyp
ml
b
confer
presenc
ermb
ermam
gene
encod
enzym
methylas
rrna
enzym
chang
rrna
bacteri
ribosom
methyl
adenin
make
unsuscept
ml
b
antibiot
recent
strain
harbour
erma
gene
found
similar
phenotyp
ermb
case
product
methylas
induc
second
wellknown
mechan
pneumonia
depend
efflux
member
macrolid
confer
phenotyp
depend
low
level
resist
member
macrolid
suscept
member
macrolid
lincosamid
streptogramin
ketolid
efflux
mechan
mediat
presenc
gene
mefa
mefe
gene
belong
mefa
group
gene
mef
believ
encod
hydrophob
membran
protein
use
energi
proton
motiv
forc
pump
macrolid
outsid
cell
recent
four
addit
mechan
phenotyp
connect
target
modif
describ
among
clinic
pneumonia
isol
first
phenotyp
ms
macrolid
streptogramin
resist
effect
substitut
three
aminoacid
highli
conserv
region
ribosom
protein
second
relat
phenotyp
confer
addit
resist
ketolid
due
substitut
six
aminoacid
protein
phenotyp
ml
macrolidelincosamid
due
chang
number
escherichia
coli
two
four
four
copi
rrna
phenotyp
similar
laboratoryobtain
mutant
resist
macrolid
recent
new
mechan
depend
mutat
rrna
describ
mutat
v
domain
four
copi
rrna
confer
resist
member
macrolid
streptogramin
b
strain
remain
suscept
macrolid
ketolid
lincosamid
frequent
first
mlsb
phenotyp
found
frequent
resist
tetracyclin
pneumonia
confer
presenc
one
two
determin
tetm
teto
gene
encod
ribosom
protect
protein
homolog
elong
factor
g
tu
protein
gtpase
activ
appear
import
displac
tetracyclin
ribosom
tetm
determin
locat
conjug
transposon
plasmid
locat
teto
thought
chromosom
definit
known
resist
chloramphenicol
determin
synthesi
chloramphenicol
acetylas
inactiv
drug
resist
compon
cotrimoxazol
confer
modif
target
chang
enzym
dihydroptero
synthetas
dhp
case
sulphonamid
dihydrofol
reductas
dhr
case
trimethoprim
suscept
drug
action
still
activ
metabol
pathway
pyogen
respons
varieti
commun
acquir
diseas
probabl
one
bacteri
pathogen
often
encount
clinic
practic
penicillin
drug
choic
treatment
infect
pyogen
macrolid
antibiot
recommend
altern
treatment
spite
extens
use
penicillin
blactam
antibiot
pyogen
remain
suscept
antibiot
howev
high
rate
resist
erythromycin
report
sever
countri
moreov
resist
antibiot
like
tetracyclin
chloramphenicol
sulphonamid
trimethoprim
occur
pyogen
strain
resist
macrolid
pneumonia
may
confer
sever
mechan
frequent
depend
methyl
rrna
lead
crossresist
macrolid
lincosamid
streptogramin
b
mlsb
two
gene
determin
resist
pyogen
recognis
ermtr
ermam
ermb
second
mechan
known
phenotyp
depend
macrolid
efflux
determin
gene
mefa
sever
strain
resist
tetracyclin
ident
mechan
pneumonia
determin
protein
tetm
respons
ribosom
protect
rare
strain
resist
chloramphenicol
due
product
acetyltransferas
cat
resist
sulphonamid
trimethoprim
determin
chang
appropri
enzym
h
influenza
uniformli
suscept
aminopenicillin
first
strain
produc
blactamas
appear
number
resist
strain
still
grow
sourc
estim
preval
h
influenza
strain
produc
blactamas
high
resist
tetracyclin
chloramphenicol
sulphonamid
trimethoprim
recent
quinolon
also
occur
bacteria
two
mechan
tetracyclin
resist
describ
h
influenza
one
depend
activ
efflux
determin
presenc
one
two
gene
tetb
tetk
encod
hydrophob
membran
protein
use
energi
proton
motiv
forc
pump
tetracyclin
cell
second
connect
presenc
ribosom
protect
protein
tetm
resist
chloramphenicol
determin
synthesi
chloramphenicol
acetyltransferas
resist
sulphonamid
trimethoprim
result
presenc
alter
form
appropri
enzym
strain
h
influenza
still
highli
suscept
fluoroquinolon
recent
report
show
resist
strain
alreadi
appear
frequenc
grow
proport
growth
fluoroquinolon
usag
resist
effect
mutat
gene
determin
bacteri
topoisomeras
sever
report
suggest
h
influenza
isol
requir
least
one
amino
acid
substitut
subunit
gyras
gyra
topoisomeras
iv
parc
order
attain
signific
level
resist
quinolon
h
influenza
produc
blactamas
type
rob
strain
produc
tem
blactamas
frequent
type
blactamas
sensit
inhibitor
like
clavulan
acid
blactamas
product
well
resist
antibiot
h
influenza
associ
presenc
larg
chromosom
integr
conjug
plasmid
last
year
proport
h
influenza
strain
resist
ampicillin
produc
blactamas
grow
blnar
blactamas
neg
ampicillin
resist
strain
possess
chang
pbp
respons
lower
affin
ampicillin
frequent
mutat
localis
gene
ftsi
encod
pbp
andor
pbp
involv
septal
peptidoglycan
synthesi
role
mutat
gene
dacb
encod
pbp
confirm
possibl
yet
unknown
mechan
ampicillin
resist
exist
among
blnar
h
influenza
countri
resist
aminoglycosid
h
influenza
high
case
due
product
aph
investig
efflux
mechan
h
influenza
show
inactiv
gene
homolog
e
coli
acrab
confer
hypersuscept
sever
antibiot
dye
eg
erythromycin
rifampicin
novobiocin
ethidium
bromid
crystal
violet
major
clinic
isol
catarrhali
suscept
penicillin
g
well
aminopenicillin
strain
produc
blactamas
blactamas
produc
catarrhali
bro
gene
appear
locat
chromosom
encod
polypeptid
differ
one
aminoacid
product
type
enzym
constitut
express
lipoprotein
associ
outer
membran
lipoprotein
precursor
blactamas
well
known
among
gramposit
bacteria
uncharacterist
gramneg
speci
fortun
organ
remain
almost
uniformli
suscept
antibiot
penicillin
cephalosporin
macrolid
tetracyclin
blactamas
inhibitor
combin
fluoroquinolon
cotrimoxazol
occasion
strain
resist
agent
appear
frequent
resist
tetracyclin
determin
tetb
protein
caus
efflux
antibiot
although
resist
bacteri
strain
isol
poland
commun
acquir
respiratori
tract
infect
high
increas
although
resist
much
greater
problem
among
hospit
acquir
infect
especi
case
staphylococci
enterococci
resist
among
commun
acquir
microorgan
also
problem
especi
bacteria
isol
children
risk
high
high
level
carriag
respiratori
pathogen
among
children
easili
spread
day
nurseri
kindergarten
school
